𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Type II collagen screening in the human chondrodysplasias

✍ Scribed by Horton, William A. ;Campbell, Dianna ;Machado, Mirta A. ;Chou, Jean


Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
489 KB
Volume
34
Category
Article
ISSN
0148-7299

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Phenylbutyrate decreases type I collagen
✍ David C. Rishikof; Dennis A. Ricupero; Hanqiao Liu; Ronald H. Goldstein πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 306 KB

## Abstract Fibrotic lung diseases are characterized by excess extracellular matrix production, in particular type I collagen. Phenylbutyrate (PB) is a non‐toxic pharmacological compound that functions as a weak histone deacetylase inhibitor. In hepatic stellate cells, the synthesis of type I colla

Small deletions in the type II collagen
✍ Wilkin, Douglas J.; Artz, Andrew S.; South, Sarah; Lachman, Ralph S.; Rimoin, Da πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 57 KB

Kniest dysplasia is a moderately severe type II collagenopathy, characterized by short trunk and limbs, kyphoscoliosis, midface hypoplasia, severe myopia, and hearing loss. Mutations in the gene that encodes type II collagen (COL2A1), the predominant protein of cartilage, have been identified in a n

Canine chondrocytes seeded in type I and
✍ Nehrer, Stefan ;Breinan, Howard A. ;Ramappa, Arun ;Shortkroff, Sonya ;Young, Gre πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 469 KB

Synthetic and natural absorbable polymers have been used as vehicles for implantation of cells into cartilage defects to promote regeneration of the articular joint surface. Implants should provide a pore structure that allows cell adhesion and growth, and not provoke inflammation or toxicity when i